WO2010107285A3 - Volume production method for growth factor using mesenchymal stem cells derived from the fetus in amniotic fluid - Google Patents
Volume production method for growth factor using mesenchymal stem cells derived from the fetus in amniotic fluid Download PDFInfo
- Publication number
- WO2010107285A3 WO2010107285A3 PCT/KR2010/001728 KR2010001728W WO2010107285A3 WO 2010107285 A3 WO2010107285 A3 WO 2010107285A3 KR 2010001728 W KR2010001728 W KR 2010001728W WO 2010107285 A3 WO2010107285 A3 WO 2010107285A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fetus
- stem cells
- mesenchymal stem
- cells derived
- amniotic fluid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to mesenchymal stem cells derived from the fetus in amniotic fluid and more specifically to mesenchymal stem cells derived from the fetus in amniotic fluid, a method for making the same, a conditioned culture medium composition made using the same, and a volume production method for human growth factor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090024054A KR101119225B1 (en) | 2009-03-20 | 2009-03-20 | Large scale production of growth promoting factors using fetus-derived mesenchymal stem cells from amniotic fluids |
KR10-2009-0024054 | 2009-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010107285A2 WO2010107285A2 (en) | 2010-09-23 |
WO2010107285A3 true WO2010107285A3 (en) | 2011-01-27 |
Family
ID=42740150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/001728 WO2010107285A2 (en) | 2009-03-20 | 2010-03-19 | Volume production method for growth factor using mesenchymal stem cells derived from the fetus in amniotic fluid |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101119225B1 (en) |
WO (1) | WO2010107285A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101371690B1 (en) * | 2011-07-12 | 2014-03-12 | 주식회사 스템메디언스 | Large scale production of growth promoting factors using fetus-derived mesenchymal stem cells from amniotic fluids with hypoxic condition and composition for regenerating skin using the same |
KR101354826B1 (en) * | 2011-12-08 | 2014-01-27 | 아주대학교산학협력단 | Screening method of the materials for prevention or treatment of osteoporosis using leptin production in mesenchymal stem cell |
KR102126331B1 (en) * | 2012-02-23 | 2020-06-25 | 주식회사 탑셀바이오 | Method for preparing conditioned medium powder |
KR101566450B1 (en) * | 2015-04-03 | 2015-11-05 | (유)스템메디케어 | A Method for mass production of proteins from mesenchymal stem cells |
KR102522295B1 (en) * | 2022-08-30 | 2023-04-18 | 주식회사 스마트셀랩 | Isolation and culture conditions of peripheral blood-derived stem cells and induction of differentiation into progenitor cells using them |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050054093A1 (en) * | 2003-08-14 | 2005-03-10 | Martin Haas | Multipotent amniotic fetal stem cells |
WO2008036447A2 (en) * | 2006-06-26 | 2008-03-27 | Lifescan, Inc. | Pluripotent stem cell culture |
-
2009
- 2009-03-20 KR KR1020090024054A patent/KR101119225B1/en active IP Right Grant
-
2010
- 2010-03-19 WO PCT/KR2010/001728 patent/WO2010107285A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050054093A1 (en) * | 2003-08-14 | 2005-03-10 | Martin Haas | Multipotent amniotic fetal stem cells |
WO2008036447A2 (en) * | 2006-06-26 | 2008-03-27 | Lifescan, Inc. | Pluripotent stem cell culture |
Non-Patent Citations (2)
Title |
---|
HUMAN REPRODUCTION, vol. 19, no. 6, 2004, pages 1450 - 1456 * |
NATURE BIOTECH., vol. 25, no. 1, January 2007 (2007-01-01), pages 100 - 106 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010107285A2 (en) | 2010-09-23 |
KR20100105165A (en) | 2010-09-29 |
KR101119225B1 (en) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247954A1 (en) | Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same | |
WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
WO2010129294A3 (en) | Small molecules supporting pluripotent cell growth and methods thereof | |
PL2393917T3 (en) | Culture medium for epithelial stem cells and organoids comprising said stem cells. | |
EP2545928A4 (en) | Cell preparation containing mesenchymal stem cells, and method for producing same | |
WO2011061032A3 (en) | Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids | |
EP2438161B1 (en) | Method for producing induced pluripotent stem cells and method for culturing the same | |
WO2010048417A3 (en) | Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products | |
WO2008129563A3 (en) | Human mesenchymal stem cells and preparation thereof | |
EP2594636A4 (en) | Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same | |
EP2046946B8 (en) | Pluripotent stem cell culture | |
EP2048227A3 (en) | Methods for proliferating stem cells | |
WO2008148105A8 (en) | Endometrial stem cells and methods of making and using same | |
WO2008007082A3 (en) | Cell growth medium | |
EP3539380A3 (en) | Improved cell composition and methods of making the same | |
WO2012057486A3 (en) | Cosmetic bio-cellulose mask pack sheet and method for manufacturing same | |
AU2011372711B2 (en) | Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress | |
WO2010107286A3 (en) | Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluid | |
WO2010149597A3 (en) | 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS | |
WO2009149956A3 (en) | Fusion protein and use thereof | |
WO2009102569A3 (en) | Cell lines and methods for making and using them | |
WO2010093655A3 (en) | Enhanced method for producing stem-like cells from somatic cells | |
WO2011000879A3 (en) | A method for producing a fermented milk product | |
WO2012098537A8 (en) | Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells | |
WO2012003402A3 (en) | Compositions and methods for culturing microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10753735 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10753735 Country of ref document: EP Kind code of ref document: A2 |